{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:31:31Z","timestamp":1790775091182,"version":"4.1.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Alcohol biomarkers can improve detection of heavy alcohol use in clinical care, yet cutoffs for phosphatidylethanol (PEth), a blood biomarker, have not been established.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine the optimal cutoff for PEth for heavy alcohol consumption in a study of middle-age and older adults.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This was a 4-week diagnostic study of adults with paroxysmal atrial fibrillation (AF) and current alcohol consumption, recruited from general cardiology and cardiac electrophysiology outpatient clinics from September 2014 to September 2019. Data were analyzed from October 2021 to March 2022.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main aim was to determine the optimal PEth cutoff for heavy alcohol consumption, using the Secure Continuous Remote Alcohol Monitor (SCRAM) to measure transdermal alcohol. Area under the curve (AUC) for PEth-detected compared with SCRAM-detected heavy alcohol consumption in any week over the prior 4 weeks (ie, \u22653 [women] and \u22654 [men] episodes) or any estimated breath alcohol of 0.08% or greater in any week, and the PEth cutoff was calculated using the Youden J statistic. Similar analyses were conducted comparing PEth with individual drinks reported by pressing an event monitor, retrospective self-report via the Alcohol Use Disorders Identification Test\u2013Consumption (AUDIT-C), and using 2-week look-backs.<\/jats:p><\/jats:sec>Results<\/jats:title>In this diagnostic study of 64 patients with both PEth and SCRAM measures over 4 weeks (54 [84.4%] men; mean age, 65.5 [95% CI, 62.6-68.5] years; 51 [79.7%] White), 31 (48.4%) had any SCRAM-detected heavy alcohol consumption over the 4 weeks, and the median (IQR) PEth at 4 weeks was 23 ng\/mL (&amp;lt;limit of quantification to 60 ng\/mL). The AUC for PEth vs any SCRAM-detected heavy alcohol consumption was 0.83 (95% CI, 0.72-0.93). The optimal PEth cutoff was 18.5 ng\/mL (AUC, 0.83; 95% CI, 0.72-0.93), with sensitivity of 83.9% (95% CI, 66.3%-94.5%) and specificity of 72.7% (95% CI, 54.5%-86.7%). The PEth test characteristics by individual drink reporting using the event monitors and by the AUDIT-C, and by these measures and by SCRAM collected for 2-week intervals, were similar to those compared with the 4-week SCRAM.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In a predominately middle-age and older White male population, PEth compared well with SCRAM. A PEth cutoff of 18.5 ng\/mL (or rounded to 20 ng\/mL, a recommended PEth cutoff for significant alcohol consumption) can be used in clinical care to detect heavy alcohol consumption in middle-age and older men.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.33182","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T15:03:55Z","timestamp":1694531035000},"page":"e2333182","source":"Crossref","is-referenced-by-count":26,"title":["Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults"],"prefix":"10.1001","volume":"6","author":[{"given":"Judith A.","family":"Hahn","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Fatch","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Barnett","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Social Sciences and the Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Marcus","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"issue":"39","key":"zoi230960r1","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.15585\/mmwr.mm6939a6","article-title":"Deaths and years of potential life lost from excessive alcohol use: United States, 2011-2015.","volume":"69","author":"Esser","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"zoi230960r3","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1001\/jama.2018.16789","article-title":"Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"zoi230960r4","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/acer.v45.6","article-title":"A cascade of care for alcohol use disorder: using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care.","volume":"45","author":"Mintz","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"zoi230960r5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/acer.v47.1","article-title":"Is clinicians\u2019 alcohol consumption associated with their preventive practices to reduce unhealthy alcohol use? a systematic review of current evidence.","volume":"47","author":"Romero-Rodr\u00edguez","year":"2023","journal-title":"Alcohol (Hanover)"},{"issue":"4","key":"zoi230960r6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/alcalc\/agh070","article-title":"Self-report and biomarker alcohol screening by primary care physicians: the need to translate research into guidelines and practice.","volume":"39","author":"Miller","year":"2004","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"zoi230960r7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/alcalc\/agl022","article-title":"Patient attitudes towards self-report and biomarker alcohol screening by primary care physicians.","volume":"41","author":"Miller","year":"2006","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"zoi230960r8","first-page":"115","article-title":"Drinking over the lifespan: focus on older adults.","volume":"38","author":"Barry","year":"2016","journal-title":"Alcohol Res"},{"issue":"3","key":"zoi230960r9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/biom5031339","article-title":"Biomolecules and biomarkers used in diagnosis of alcohol drinking and in monitoring therapeutic interventions.","volume":"5","author":"Nanau","year":"2015","journal-title":"Biomolecules"},{"issue":"11","key":"zoi230960r10","doi-asserted-by":"publisher","first-page":"14788","DOI":"10.3390\/ijms131114788","article-title":"Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis.","volume":"13","author":"Viel","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"6","key":"zoi230960r11","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/acer.13062","article-title":"Characterization of the pharmacokinetics of phosphatidylethanol 16:0\/18:1 and 16:0\/18:2 in human whole blood after alcohol consumption in a clinical laboratory study.","volume":"40","author":"Javors","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"zoi230960r12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00414-016-1445-x","article-title":"Phosphatidylethanol (PEth) detected in blood for 3 to 12 days after single consumption of alcohol\u2014a drinking study with 16 volunteers.","volume":"131","author":"Schrock","year":"2017","journal-title":"Int J Legal Med"},{"issue":"9","key":"zoi230960r13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/acer.2012.36.issue-9","article-title":"Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days.","volume":"36","author":"Gnann","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"zoi230960r14","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/jfo.2018.63.issue-6","article-title":"The PEth blood test in the security environment: what it is; why it is important; and interpretative guidelines.","volume":"63","author":"Ulwelling","year":"2018","journal-title":"J Forensic Sci"},{"issue":"6","key":"zoi230960r15","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/acer.v45.6","article-title":"Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: an individual patient data meta-analysis.","volume":"45","author":"Hahn","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"zoi230960r16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/adb.2007.12.issue-1","article-title":"Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin.","volume":"12","author":"Hartmann","year":"2007","journal-title":"Addict Biol"},{"issue":"4","key":"zoi230960r17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/alcalc\/agl027","article-title":"PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.","volume":"41","author":"Aradottir","year":"2006","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"zoi230960r18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/alcalc\/agv038","article-title":"Phosphatidylethanol compared with other blood tests as a biomarker of moderate alcohol consumption in healthy volunteers: a prospective randomized study.","volume":"50","author":"Kechagias","year":"2015","journal-title":"Alcohol Alcohol"},{"issue":"6","key":"zoi230960r19","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/acer.2014.38.issue-6","article-title":"Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.","volume":"38","author":"Stewart","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"zoi230960r20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/acer.2010.34.issue-3","article-title":"Phosphatidylethanol and alcohol consumption in reproductive age women.","volume":"34","author":"Stewart","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"zoi230960r21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/alcalc\/agad015","article-title":"Quantifying alcohol consumption in the general population by analysing phosphatidylethanol concentrations in whole blood: results from 24,574 subjects included in the HUNT4 Study.","volume":"58","author":"Skr\u00e5stad","year":"2023","journal-title":"Alcohol Alcohol"},{"issue":"11","key":"zoi230960r22","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.7326\/M21-0228","article-title":"Acute consumption of alcohol and discrete atrial fibrillation events.","volume":"174","author":"Marcus","year":"2021","journal-title":"Ann Intern Med"},{"key":"zoi230960r23","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"zoi230960r24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1039\/c0ay00636j","article-title":"The detection of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol in human dried blood spots.","volume":"3","author":"Jones","year":"2011","journal-title":"Anal Methods"},{"issue":"4","key":"zoi230960r25","doi-asserted-by":"publisher","DOI":"10.2196\/35178","article-title":"Accuracy of wearable transdermal alcohol sensors: systematic review.","volume":"24","author":"Brobbin","year":"2022","journal-title":"J Med Internet Res"},{"issue":"7","key":"zoi230960r26","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/acer.2007.31.issue-7","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care.","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"23","key":"zoi230960r27","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1161\/CIRCULATIONAHA.113.002449","article-title":"Incident atrial fibrillation among Asians, Hispanics, Blacks, and Whites.","volume":"128","author":"Dewland","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"zoi230960r29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1037\/a0034821","article-title":"Predictors of detection of alcohol use episodes using a transdermal alcohol sensor.","volume":"22","author":"Barnett","year":"2014","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"zoi230960r30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests.","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"issue":"12","key":"zoi230960r31","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/acer.14475","article-title":"Relationship of phosphatidylethanol biomarker to self-reported alcohol drinking patterns in older and middle-age adults.","volume":"44","author":"Cherrier","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"zoi230960r32","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/dta.3340","article-title":"Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel).","volume":"14","author":"Luginb\u00fchl","year":"2022","journal-title":"Drug Test Anal"},{"key":"zoi230960r28","author":"Barnett"},{"key":"zoi230960r2","unstructured":"National Institute of Alcohol Abuse and Alcoholism. Drinking levels defined. Accessed July 1, 2016. https:\/\/www.niaaa.nih.gov\/alcohol-health\/overview-alcohol-consumption\/moderate-binge-drinking"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2809197\/hahn_2023_oi_230960_1693507884.80211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T15:04:00Z","timestamp":1694531040000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2809197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.33182","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}